Possible Prophylactic Effects of Sulforaphane on LPS-Induced Recognition Memory Impairment Mediated by Regulating Oxidative Stress and Neuroinflammatory Proteins in the Prefrontal Cortex Region of the Brain

• Published in: Biomedicines 2024-05, Vol.12 (5), p.1107
• Main Authors: Alzahrani, Noor Ahmed, Bahaidrah, Khulud Abdullah, Mansouri, Rasha A, Aldhahri, Rahaf Saeed, Abd El-Aziz, Gamal S, Alghamdi, Badrah S
• Format: Article
• Language: English
• Subjects: Acetylcholinesterase; Alzheimer's disease; Analysis; Animal cognition; Antioxidants; Behavior; Body temperature; Body weight; Brain; Brain research; Caspase-3; Cognitive ability; Dementia; Drug therapy; Enzymes; Hyperactivity; Immunohistochemistry; Inflammation; Investigations; Lipopolysaccharides; Memory; Neurodegeneration; Neurodegenerative diseases; neuroinflammation; Oxidants; Oxidative stress; Pattern recognition; Prefrontal cortex; Public health; recognition memory; Sulforaphane; Temperature; Temporal lobe; Temporal variations; β-Amyloid
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12051107

Alzheimer's disease (AD) presents a significant global health concern, characterized by neurodegeneration and cognitive decline. Neuroinflammation is a crucial factor in AD development and progression, yet effective pharmacotherapy remains elusive. Sulforaphane (SFN), derived from cruciferous vegetables and mainly from broccoli, has shown a promising effect via in vitro and in vivo studies as a potential treatment for AD. This study aims to investigate the possible prophylactic mechanisms of SFN against prefrontal cortex (PFC)-related recognition memory impairment induced by lipopolysaccharide (LPS) administration. Thirty-six Swiss (SWR/J) mice weighing 18-25 g were divided into three groups ( = 12 per group): a control group (vehicle), an LPS group (0.75 mg/kg of LPS), and an LPS + SFN group (25 mg/kg of SFN). The total duration of the study was 3 weeks, during which mice underwent treatments for the initial 2 weeks, with daily monitoring of body weight and temperature. Behavioral assessments via novel object recognition (NOR) and temporal order recognition (TOR) tasks were conducted in the final week of the study. Inflammatory markers (IL-6 and TNF), antioxidant enzymes (SOD, GSH, and CAT), and pro-oxidant (MDA) level, in addition to acetylcholine esterase (AChE) activity and active (caspase-3) and phosphorylated (AMPK) levels, were evaluated. Further, PFC neuronal degeneration, Aβ content, and microglial activation were also examined using H&E, Congo red staining, and Iba1 immunohistochemistry, respectively. SFN pretreatment significantly improved recognition memory performance during the NOR and TOR tests. Moreover, SFN was protected from neuroinflammation and oxidative stress as well as neurodegeneration, Aβ accumulation, and microglial hyperactivity. The obtained results suggested that SFN has a potential protective property to mitigate the behavioral and biochemical impairments induced by chronic LPS administration and suggested to be via an AMPK/caspase-3-dependent manner.